1993
DOI: 10.1161/01.cir.87.2.659
|View full text |Cite
|
Sign up to set email alerts
|

Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
72
0
6

Year Published

1994
1994
2015
2015

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 204 publications
(80 citation statements)
references
References 170 publications
2
72
0
6
Order By: Relevance
“…In 1993, the American Heart Association (AHA) officially recommended use of aspirin as a therapeutic agent for the prevention of cardiovascular disease. 25 We noted an increase in aspirin use from 10.8% in the 1992 study by Tofler recent studies have demonstrated that clock genes in human cardiac tissue display significant time-dependent transcriptional variation with peak expression of some clock genes and trough expression of others coinciding with myocardial incidents. 43 Morning hours may also represent nadir levels of some cardioprotective medications.…”
Section: Discussionmentioning
confidence: 74%
“…In 1993, the American Heart Association (AHA) officially recommended use of aspirin as a therapeutic agent for the prevention of cardiovascular disease. 25 We noted an increase in aspirin use from 10.8% in the 1992 study by Tofler recent studies have demonstrated that clock genes in human cardiac tissue display significant time-dependent transcriptional variation with peak expression of some clock genes and trough expression of others coinciding with myocardial incidents. 43 Morning hours may also represent nadir levels of some cardioprotective medications.…”
Section: Discussionmentioning
confidence: 74%
“…ASA prevents thrombus formation and has an antiplatelet effect, which might prevent stenosis in the previously grafted vessels [5]. Additionally, this drug has anti-inflammatory properties [6].…”
Section: Introductionmentioning
confidence: 99%
“…4,5 Over 30 years of experience has accrued with the use of aspirin after cardiac surgery, and essentially all patients undergoing CABG are candidates for long-term aspirin therapy. 6 Aspirin inhibition of platelet function after CABG helps maintain graft patency and prevent major adverse cardiovascular events.…”
mentioning
confidence: 99%